EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Abnormal Glucagon Secretion Contributes to a Longitudinal Decline in Glucose Tolerance

Sneha Mohan iD, Hannah E Christie iD, Marcello C Laurenti, Aoife M Egan iD, Kent R Bailey, Claudio Cobelli iD, Chiara Dalla Man iD, Adrian Vella iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae915 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Sneha Mohan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Glucagon, Glucose Intolerance, Diabetes Mellitus, Type 2, Prediabetic State. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mayo Clinic General Clinical Research Center, NCATS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Defects in insulin secretion and action contribute to the progression of prediabetes to diabetes. However, the contribution of α-cell dysfunction to this process has been unclear.

Objective

This work aimed to understand the relative contributions of α-cell and β-cell dysfunction to declining glucose tolerance.

Methods

A longitudinal, community-based observational study was conducted at a clinical research unit at an academic medical center. We studied 96 individuals without diabetes (age 55 ± 1 years; body mass index 27.7 ± 0.4) on 2 occasions, 3 years apart using an oral 75-g glucose challenge. Indices for insulin secretion and action were estimated using the oral minimal model. Glucagon secretion rate (GSR) was estimated by deconvolution from peripheral glucagon concentrations. Main outcome measures included glucose tolerance status (categorical variable) and then symmetrical percentage change in peak and 120-minute glucose (post oral glucose tolerance test) concentrations (continuous variables).

Results

A total of 32 individuals progressed from normal to impaired glucose tolerance (IGT) or from IGT to type 2 diabetes. The disposition index (DI) declined in the progressors (568 ± 98 vs 403 ± 65 10−4 dL/kg/min per μU/mL, baseline vs 3 years; P = .04). α-Cell suppression by glucose (δGSR/δglucose) did not change in the nonprogressors (1.5 ± 0.1 vs 1.3 ± 0.1 nmol/min/L; P = .37) but decreased (1.0 ± 0.2 vs 0.8 ± 0.2 nmol/min/L; P < .01) in those who progressed. Analysis of the entire cohort showed that DI and δGSR/δglucose were independently and inversely correlated with an increase in glycemic excursion.

Conclusion

These data show that α-cell dysfunction accompanies a decline in β-cell function as IGT or overt type 2 diabetes develops.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucagonGlucose IntoleranceDiabetes Mellitus, Type 2Prediabetic StateGlucagon-Secreting CellsHumansMiddle AgedMaleFemaleLongitudinal StudiesGlucose Tolerance TestInsulin-Secreting CellsDisease ProgressionBlood GlucoseInsulin SecretionAdultAged

Stichwörter der Autor:innen

glucagon suppressioninsulin secretionprediabetesα-cell functionβ-cell function

Substanzen

GlucagonBlood Glucose

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
  • Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Women and Children's Health, University of Padova, Via Giustiniani, 3, 35128 Padova, Italy.
  • Department of Information Engineering, University of Padova, Via G. Gradenigo 6/b, 35131 Padova, Italy.

ORCID-Profile: Sneha Mohan, Hannah E Christie, Aoife M Egan, Claudio Cobelli, Chiara Dalla Man, Adrian Vella

Förderung

  • Mayo Clinic General Clinical Research Center
  • NCATS NIH HHS
  • NIDDK NIH HHS
  • MIUR (Italian Minister for Education
  • )

Zitieren

APA

Mohan, S., Christie, H. E., Laurenti, M. C., Egan, A. M., Bailey, K. R., Cobelli, C., Dalla Man, C., & Vella, A. (2025). Abnormal Glucagon Secretion Contributes to a Longitudinal Decline in Glucose Tolerance. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae915

Vancouver

Mohan S, Christie HE, Laurenti MC, Egan AM, Bailey KR, Cobelli C, et al. Abnormal Glucagon Secretion Contributes to a Longitudinal Decline in Glucose Tolerance. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae915

BibTeX
@article{Mohan2025,
  author = {Mohan, Sneha and Christie, Hannah E and Laurenti, Marcello C and Egan, Aoife M and Bailey, Kent R and Cobelli, Claudio and Dalla Man, Chiara and Vella, Adrian},
  title = {Abnormal Glucagon Secretion Contributes to a Longitudinal Decline in Glucose Tolerance},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae915}
}
Kostenlos starten →